Global Cord Blood Shares Rise 15% After Merger Target Gets FDA Clearance for IND
By Chris Wack Global Cord Blood Corp. shares were up 15% to $3.42 after the company ...
Read moreBy Chris Wack Global Cord Blood Corp. shares were up 15% to $3.42 after the company ...
Read moreThe U.S. Food and Drug Administration (FDA) has cleared Global Cord Blood Corporation’s CO Investigational New ...
Read moreWhat happened After market hours on Wednesday, Global Blood Therapeutics (GBT -7.96%) released a first-quarter earnings ...
Read more© 2022 TheDailyStock.News